51 results
Page 2 of 3
F-3
iamj8z
28 Jun 22
Shelf registration (foreign)
4:49pm
6-K
EX-99.3
4xqvcebyk9
20 May 22
Interim Report January 1ST – March 31ST 2022
4:34pm
6-K
EX-99.1
326xucpuc8zeazr9zk
20 May 22
Interim Report January 1ST – March 31ST 2022
4:34pm
6-K
EX-99.1
cue754e
29 Apr 22
Current report (foreign)
4:02pm
6-K
EX-99.2
nhrk8fm ve9
24 Feb 22
Current report (foreign)
4:05pm
20-F/A
EX-15.1
pv8umz3a2e05ql 0ov
14 Jan 22
Annual report (foreign) (amended)
5:13pm
6-K
EX-99.1
1omv3i
20 Aug 21
Current report (foreign)
5:28pm
424B5
rdnx20m
12 Aug 21
Prospectus supplement for primary offering
5:10pm
6-K
EX-10.1
vdmouy q4k
23 Jul 21
Calliditas Therapeutics and STADA partner to register and commercialize specialty therapy for IgA Nephropathy in Europe
4:03pm
F-3ASR
EX-3.1
b7x 0faoiddx9z6a5g55
12 Jul 21
Automatic shelf registration (foreign)
5:10pm
F-3ASR
pdcrgzp33g jyydd2pt
12 Jul 21
Automatic shelf registration (foreign)
5:10pm
6-K
EX-99.2
soa zhas8
18 May 21
Filing of New Drug Application submission to the FDA
9:00am
20-F
EX-2.4
7qw17sv u78
27 Apr 21
Annual report (foreign)
5:16pm
20-F
m34v1akqklqalpo
27 Apr 21
Annual report (foreign)
5:16pm
6-K
EX-99.1
hx8j6v
27 Apr 21
Current report (foreign)
12:00am
6-K
EX-99.2
bubkayhvc g32a4x871v
18 Feb 21
Positive Topline Results from Pivotal Phase 3 NefIgArd Trial
8:01am
F-1
62k dnllb56
26 Jan 21
Registration statement (foreign)
4:33pm